Found: 17
Select item for more details and to access through your institution.
Meta‐analysis: hepatitis B reactivation in patients receiving biological therapy.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 7, p. 1104, doi. 10.1111/apt.17155
- By:
- Publication type:
- Article
Editorial: trends in the epidemiology of inflammatory bowel disease in Korea.
- Published in:
- 2022
- Publication type:
- Editorial
Editorial: rising rates of venous thromboembolism among hospitalised patients with inflammatory bowel disease in the USA—authors' reply.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Letter: efficacy of peppermint oil in irritable bowel syndrome—authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 7, p. 1217, doi. 10.1111/apt.17197
- By:
- Publication type:
- Article
Editorial: rising rates of venous thromboembolism among hospitalised patients with inflammatory bowel disease in the USA.
- Published in:
- 2022
- Publication type:
- Editorial
Letter: efficacy of peppermint oil in irritable bowel syndrome.
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
Use of statins after liver transplantation is associated with improved survival: results of a nationwide study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 7, p. 1194, doi. 10.1111/apt.17192
- By:
- Publication type:
- Article
Autoimmune hepatitis and metabolic syndrome‐associated disease development: a U.S. cohort study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 7, p. 1183, doi. 10.1111/apt.17191
- By:
- Publication type:
- Article
Editorial: cooking up something new for diet therapy of eosinophilic oesophagitis.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Review article: guide to tofacitinib dosing in patients with ulcerative colitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 7, p. 1131, doi. 10.1111/apt.17185
- By:
- Publication type:
- Article
Editorial: trends in the epidemiology of inflammatory bowel disease in Korea – author's reply.
- Published in:
- 2022
- Publication type:
- Editorial
Colorectal cancer in elderly‐onset inflammatory bowel disease: a 1969–2017 Scandinavian register‐based cohort study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 7, p. 1168, doi. 10.1111/apt.17175
- By:
- Publication type:
- Article
Extrahepatic morbidities and mortality of NAFLD: an umbrella review of meta‐analyses.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 7, p. 1119, doi. 10.1111/apt.17165
- By:
- Publication type:
- Article
Increasing rates of venous thromboembolism among hospitalised patients with inflammatory bowel disease: a nationwide analysis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 7, p. 1157, doi. 10.1111/apt.17162
- By:
- Publication type:
- Article
Transmural healing evaluated by magnetic resonance enterography in paediatric patients with Crohn's disease receiving maintenance treatment with biologics.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 7, p. 1146, doi. 10.1111/apt.17161
- By:
- Publication type:
- Article
Letter: serum HBV RNA and HBcrAg may help to evaluate safely stopping nucleot(s)ide analogues in patients with HBeAg‐negative chronic hepatitis B and without cirrhosis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 7, p. 1219, doi. 10.1111/apt.17154
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 7, p. 1101, doi. 10.1111/apt.16429
- Publication type:
- Article